| For: | Zhang ZS, Gu Y, Liu BG, Tang H, Hua Y, Wang J. Oncogenic role of Tc17 cells in cervical cancer development. World J Clin Cases 2020; 8(1): 11-19 [PMID: 31970165 DOI: 10.12998/wjcc.v8.i1.11] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i1/11.htm |
| Number | Citing Articles |
| 1 |
Julia Fleecs, Eden Abrham, Mikale Kuntz, M. Nadeem Khan, Ramkumar Mathur. Colon Cancer Diagnosis and Therapy Vol. 3. 2022; doi: 10.1007/978-3-030-72702-4_9
|
| 2 |
Hui Cheng, Yanyu Li, Jie Cheng, Yanling Zhang, Bei Zhang. Study on the effect and mechanisms of piperine against cervical cancer based on network pharmacology and experimental validation. Biotechnology and Genetic Engineering Reviews 2024; 40(4) doi: 10.1080/02648725.2023.2217611
|
| 3 |
Eileen Victoria Meehan, Kepeng Wang. Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer. Genes 2022; 13(9) doi: 10.3390/genes13091643
|
| 4 |
Elizabeth H Gray, Ushani Srenathan, Lucy E Durham, Sylvine Lalnunhlimi, Kathryn J A Steel, Anca Catrina, Bruce W Kirkham, Leonie S Taams. Human in vitro-induced IL-17A+ CD8+ T-cells exert pro-inflammatory effects on synovial fibroblasts. Clinical and Experimental Immunology 2023; 214(1) doi: 10.1093/cei/uxad068
|
| 5 |
Parviz Azimnasab-Sorkhabi, Maryam Soltani-Asl, Ephraim A. Ansa-Addo, Jose Roberto Kfoury Junior. Cancer Immunology and Genetics: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 23 doi: 10.1007/16833_2024_332
|
| 6 |
Joanna Pastwińska, Iwona Karwaciak, Kaja Karaś, Rafał A. Bachorz, Marcin Ratajewski. RORγT agonists as immune modulators in anticancer therapy.. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(6) doi: 10.1016/j.bbcan.2023.189021
|
| 7 |
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, Chien-Fu Hung, T.-C. Wu. Cervical Cancer Immunotherapy: Facts and Hopes. Clinical Cancer Research 2021; 27(18) doi: 10.1158/1078-0432.CCR-20-2833
|
| 8 |
Jonathan Peña Avila, Bruno Melo Carvalho, Eliane Campos Coimbra. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities. Cancers 2023; 15(4) doi: 10.3390/cancers15041333
|
| 9 |
Selina Gies, Patrick Melchior, Russalina Stroeder, Tanja Tänzer, Laura Theobald, Maike Pohlers, Birgit Glombitza, Martina Sester, Erich‐Franz Solomayer, Barbara Walch‐Rückheim. Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL‐17 expression associated with cancer relapse. International Journal of Cancer 2024; 154(2) doi: 10.1002/ijc.34745
|